Loading...
XNAS
AZTA
Market cap1.13bUSD
Jul 09, Last price  
25.42USD
1D
3.71%
1Q
14.45%
Jan 2017
48.92%
Name

Azenta Inc

Chart & Performance

D1W1MN
XNAS:AZTA chart
P/E
P/S
1.97
EPS
Div Yield, %
Shrs. gr., 5y
-9.07%
Rev. gr., 5y
8.85%
Revenues
594m
+3.55%
607,494,000743,258,000526,366,000218,706,000592,972,000688,105,000519,451,000422,440,000482,848,000552,708,000560,323,000527,499,000631,560,000780,848,000388,537,000513,703,000555,498,000665,072,000573,448,000593,821,000
Net income
-56m
L-66.18%
25,930,00067,574,000-236,625,000-227,858,00058,982,000128,352,000136,789,000-2,215,0004,461,00014,221,000-69,476,00062,612,000116,575,00028,816,00064,852,999110,747,000-428,961,000-14,257,000-164,897,000-55,763,000
CFO
72m
+45.11%
65,192,00072,873,00013,656,000-56,494,00027,872,00087,650,00036,038,00054,389,00053,781,00043,727,00039,547,00096,224,00073,964,00090,898,00037,866,000149,857,000-466,046,0005,834,00049,743,00072,181,000
Dividend
Dec 02, 20210.1 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
IPO date
Feb 02, 1995
Employees
4,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT